Mendus AB: Mendus to participate in upcoming conferences in
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation...
Source: globenewswire.com
Page 7 - Valency Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Valency Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Valency Communications Today - Breaking & Trending Today
Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition
Intratumoral injection of allogeneic pro-inflammatory dendritic cells ("ilixadencel") substantially and sustainably enhanced an otherwise ineffective systemic anti CTLA-4 treatment in an established in
Source: finanznachrichten.de
Investegate |Immunicum AB Announcements | Immunicum AB: Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB
Investegate announcements from Immunicum AB, Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB
Source: investegate.co.uk
Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB
Rebranding reflects advancing pipeline in next generation cancer immunotherapies, upcoming manufacturing expansion, and long-term corporate aspirationsThe Company's stock to continue trading under ticker
Source: finanznachrichten.de
Immunicum AB: Immunicum Announces Corporate Rebranding and
Rebranding reflects advancing pipeline in next generation cancer immunotherapies, upcoming manufacturing expansion, and long-term corporate aspirationsThe...
Source: globenewswire.com